Found 3 clinical trials
Phase 3 Study to Evaluate the Safety and Efficacy of YPEG-rhG-CSF in Malignancies Receiving Chemotherapy
Myelosuppressive Chemotherapy which is likely to cause clinically significant febrile neutropenia.
- 0 views
- 25 Jan, 2021
An Analysis to Estimate Febrile Neutropenia (FN) in Patients Receiving Udenyca
This is a multicenter, prospective, observational cohort registry in subjects receiving myelosuppressive chemotherapy for a non-myeloid malignancy who are considered to be at high risk for
- 0 views
- 27 Jan, 2021
- 3 locations
The Oronasal Microbiota in Pediatric Oncology Patients
, including those patients receiving myelosuppressive chemotherapy or undergoing hematopoietic stem cell transplantation. In these patients, organisms typically considered as commensals can become pathogenic
- 28 views
- 24 Jul, 2021
- 1 location